Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Screeners that run automatically... and then email you the results! FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Science 37 Hldgs Inc (SNCE)

Science 37 Hldgs Inc (SNCE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 71,177
  • Shares Outstanding, K 116,664
  • Annual Sales, $ 59,600 K
  • Annual Income, $ -94,330 K
  • 60-Month Beta 0.83
  • Price/Sales 1.17
  • Price/Cash Flow N/A
  • Price/Book 0.44
Trade SNCE with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.98
  • Most Recent Earnings -0.16 on 11/10/22
  • Next Earnings Date N/A
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate -0.21
  • Number of Estimates 1
  • High Estimate -0.21
  • Low Estimate -0.21
  • Prior Year -0.29
  • Growth Rate Est. (year over year) +27.59%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.5352 +7.14%
on 12/01/22
1.4400 -60.18%
on 11/08/22
-0.8616 (-60.04%)
since 11/04/22
3-Month
0.5352 +7.14%
on 12/01/22
2.0600 -72.17%
on 09/15/22
-1.0466 (-64.60%)
since 09/06/22
52-Week
0.5352 +7.14%
on 12/01/22
14.4361 -96.03%
on 12/23/21
-9.2466 (-94.16%)
since 12/06/21

Most Recent Stories

More News
Science 37 Holdings, Inc. (SNCE) Reports Q3 Loss, Misses Revenue Estimates

Science 37 Holdings, Inc. (SNCE) delivered earnings and revenue surprises of 5.88% and 21.12%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?...

SNCE : 0.5734 (-6.02%)
KMDA : 4.58 (-0.87%)
Precigen, Inc. (PGEN) Reports Q3 Loss, Lags Revenue Estimates

Precigen, Inc. (PGEN) delivered earnings and revenue surprises of -140% and 67.67%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

PGEN : 1.5800 (-9.71%)
SNCE : 0.5734 (-6.02%)
MannKind (MNKD) Reports Q3 Loss, Tops Revenue Estimates

MannKind (MNKD) delivered earnings and revenue surprises of 40% and 35.08%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

MNKD : 4.57 (-0.87%)
SNCE : 0.5734 (-6.02%)
Science 37 Reports Second Quarter 2022 Financial Results

RESEARCH TRIANGLE PARK, N.C., Aug. 11, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), (“Science 37”) the Agile Clinical Trial...

SNCE : 0.5734 (-6.02%)
OpenSesame Appoints Tamar Elkeles, PhD, and Emily Rollins to its Board of Directors

OpenSesame today announced it has appointed Tamar Elkeles, PhD, and Emily Rollins to its Board of Directors. Dr. Elkeles is a highly regarded Chief Human Resources Officer and thought leader, advising...

GPX : 20.85 (unch)
GGGVU : 10.08 (-1.37%)
DLB : 74.15 (-1.98%)
XMTR : 42.28 (-3.62%)
SNCE : 0.5734 (-6.02%)
Science 37 to Report Second Quarter 2022 Financial Results on August 11, 2022

RESEARCH TRIANGLE PARK, N.C., July 28, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™...

SNCE : 0.5734 (-6.02%)
Oncology Clinical Trial Execs to Increase Decentralization, Science 37 Survey Indicates

Almost three in four (73%) oncology research executives plan to execute either a fully decentralized or hybrid clinical trial in the next 12 months...

SNCE : 0.5734 (-6.02%)
Science 37® to Participate in Upcoming Investor Conferences

RESEARCH TRIANGLE PARK, N.C., June 07, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™,...

SNCE : 0.5734 (-6.02%)
Science 37® to Present at the William Blair 42nd Annual Growth Stock Conference

RESEARCH TRIANGLE PARK, N.C., May 25, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™,...

SNCE : 0.5734 (-6.02%)
Science 37 Introduces Virtual Site Model to Rescue Slow Enrolling Clinical Trials

New offering provides access to patients beyond the existing site network can be implemented in four weeks....

SNCE : 0.5734 (-6.02%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Science 37 Inc. provides operating system for agile clinical trials. Science 37 Inc., formerly known as LifeSci Acquisition II Corp., is based in LOS ANGELES.

See More

Key Turning Points

3rd Resistance Point 0.6827
2nd Resistance Point 0.6589
1st Resistance Point 0.6161
Last Price 0.5734
1st Support Level 0.5495
2nd Support Level 0.5257
3rd Support Level 0.4829

See More

52-Week High 14.4361
Fibonacci 61.8% 9.1260
Fibonacci 50% 7.4857
Fibonacci 38.2% 5.8453
Last Price 0.5734
52-Week Low 0.5352

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar